✦ LIBER ✦

Hiccups associated with levodopa in Parkinson's disease

✍ Scribed by Willi Gerschlager; Bastiaan R. Bloem

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 310 KB
Volume: 24
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.22395

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hiccup secondary to dopamine agonists in

Hiccup secondary to dopamine agonists in Parkinson's Disease

✍ Jacobo Lester; Gabriela Beatriz Raina; Claudia Uribe-Roca; Federico Micheli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

Hiccup is produced by a sudden contraction of the inspiratory muscles followed by an abrupt closure of the glottis, which produces the typical sound that characterizes this disorder. The causes of hiccup are diverse, 1 including several drugs. 2 Here, we report two cases of patients with Parkinson's

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—therapy: Levodopa

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to

Does papaverine interact with levodopa i

Does papaverine interact with levodopa in Parkinson's disease?

✍ J. L. Montastruc; O. Rascol; J. Belin; M. Ane; A. Rascol 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Levodopa response in early Parkinson's d

Levodopa response in early Parkinson's disease

✍ Robert A. Hauser; Peggy Auinger; David Oakes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Mood and anxiety fluctuation in Parkinso

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings

✍ Dr. Robert A. Maricle; John G. Nutt; Julie H. Carter 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 1 views

Pilot data on mood and anxiety changes in 15 Parkinson's disease patients with motor fluctuations are described based on ratings every 30 min for 5 h bracketing a 2-h constant-rate levodopa infusion. Robust mood and anxiety effects slightly preceded but temporally paralleled fluctuations in motor ta

Cysteine elevation in levodopa-treated p

Cysteine elevation in levodopa-treated patients with Parkinson's disease

✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei